The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Primaquine: the risks and the benefits
Open accessAbstract
Primaquine is the only generally available anti-malarial that prevents relapse in vivax and ovale malaria, and the only potent gametocytocide in falciparum malaria. Primaquine becomes increasingly important as malaria-endemic countries move towards elimination, and although it is widely recommended, it is commonly not given to malaria patients because of haemolytic toxicity in subjects who are glucose-6-phosphate dehydrogenase (G6PD) deficient (gene frequency typically 3-30% in malaria endemic areas; >180 different genetic variants). In six decades of primaquine use in approximately 200 million people, 14 deaths have been reported. Confining the estimate to reports with known denominators gives an estimated mortality of one in 621,428 (upper 95% CI: one in 407,807). All but one death followed multiple dosing to prevent vivax malaria relapse. Review of dose-response relationships and clinical trials of primaquine in G6PD deficiency suggests that the currently recommended WHO single low dose (0.25 mg base/kg) to block falciparum malaria transmission confers a very low risk of haemolytic toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose-6-phosphate dehydrogenase deficiency
Cappellini, M., & Fiorelli, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60073-2 · Cited by 1,590
Hematology of Infancy and Childhood.
(1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-587_2 · Cited by 892
Beutler, E. (1994) · Blood · doi:10.1182/blood.v84.11.3613.bloodjournal84113613 · Cited by 731
Determinants of relapse periodicity in Plasmodium vivax malaria
White, N. J. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-297 · Cited by 679
Self-citationBurden of Malaria in India: Retrospective and Prospective View
Kumar, A., Valecha, N., Jain, T., & Dash, A. P. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.69 · Cited by 439
Glucose-6-Phosphate Dehydrogenase Deficiency
Luzzatto, L., Nannelli, C., & Notaro, R. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.11.006 · Cited by 400
Nathan and Oski's Hematology of Infancy and Childhood
Nathan, E., & Orkin, S. H. (2002) · Cited by 384
Nathan and Oski’s Hematology of Infancy and Childhood
Mehta, P. (2009) · JAMA · doi:10.1001/jama.2009.790 · Cited by 352
Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria
Bennett, J. W., Pybus, B. S., Yadava, A., Tosh, D., Sousa, J. C., McCarthy, W. F., Deye, G., Melendez, V., & Ockenhouse, C. F. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1301936 · Cited by 293
TARLOV, A. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620140081013 · Cited by 273
Dern, R. J., Beutler, E., & Alving, A. S. (1955) · PubMed · Cited by 235
Glucose-6-Phosphate Dehydrogenase Deficiency and Antimalarial Drug Development
Beutler, E., Duparc, S., & _, _. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.779 · Cited by 215
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
Pybus, B. S., Marcsisin, S. R., Jin, X., Deye, G., Sousa, J. C., Li, Q., Caridha, D., Zeng, Q., Reichard, G. A., Ockenhouse, C., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-212 · Cited by 182
Smithuis, F., Kyaw, M. K., Phe, O., Win, T., Aung, P. P., Oo, A. P. P., Naing, A. L., Nyo, M. Y., Myint, N. Z. H., Imwong, M., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70187-0 · Cited by 177
Self-citationVivax Malaria: A Major Cause of Morbidity in Early Infancy
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Hasanuddin, A., Warikar, N., Sugiarto, P., Tjitra, E., Anstey, N. M., & Price, R. N. (2009) · Clinical Infectious Diseases · doi:10.1086/599041 · Cited by 164
Primaquine to prevent transmission of falciparum malaria
White, N. J. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70198-6 · Cited by 158
Self-citationWhite, N. J., Qiao, L. G., Gao, Q., & Luzzatto, L. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-418 · Cited by 153
Self-citationPybus, B. S., Sousa, J. C., Jin, X., Ferguson, J. A., Christian, R. E., Barnhart, R., Vuong, C. V., Sciotti, R. J., Reichard, G. A., Kozar, M. P., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-259 · Cited by 152
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Warikar, N., Seal, A., McGready, R., Sugiarto, P., Tjitra, E., Anstey, N. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/586743 · Cited by 148
Alving, A. S., JOHNSON, C. F., Tarlov, A. R., Brewer, G. J., Kellermeyer, R. W., & Carson, P. E. (1960) · Europe PMC (PubMed Central) · Cited by 144
Dern, R. J., Beutler, E., & Alving, A. S. (1954) · PubMed · Cited by 139
Kim, S., Nguon, C., Guillard, B., Socheat, D., Chy, S., Sum, S., Nhem, S., Bouchier, C., Tichit, M., Christophel, E. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028357 · Cited by 128
Shekalaghe, S., ter Braak, R., Daou, M., Kavishe, R. A., van den Bijllaardt, W., van den Bosch, S., Koenderink, J. B., Luty, A. J. F., Whitty, C. W. M., DRAKELEY, C. J., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01135-09 · Cited by 118
Eziefula, C., Bousema, T., Yeung, S., Kamya, M. R., Owaraganise, A., Gabagaya, G., Bradley, J., Grignard, L., Lanke, K. H. W., Wanzira, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70268-8 · Cited by 115
Self-citationHsiang, M. S., Hwang, J., Tao, A. R., Liu, Y., Bennett, A. F., Shanks, G. D., Cao, J., Kachur, S. P., Feachem, R. G., Gosling, R. D., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-383 · Cited by 107
Mass primaquine treatment to eliminate vivax malaria: lessons from the past
Kondrashin, A. V., Baranova, A. M., Ashley, E. A., Recht, J., White, N. J., & Sergiev, V. P. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-51 · Cited by 89
Self-citationCHANGES IN MALARIA INCIDENCE AFTER MASS DRUG ADMINISTRATION IN NICARAGUA
Garfield, R., & Vermund, S. H. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90523-8 · Cited by 75
Nosten, F. H., Imvithaya, S., Vincenti, M., Delmas, G., Lebihan, G., Häusler, B., & White, N. J. (1987) · PubMed Central · Cited by 63
Self-citationEziefula, C., Pett, H., Grignard, L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02889-14 · Cited by 42
Abeyaratne, K. P., & Nl, H. (1968) · PubMed · Cited by 20
G6PD gene mutations in India producing drug‐induced haemolytic anaemia
Sukumar, S., Colah, R. B., & Mohanty, D. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2001.03328.x · Cited by 19
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission
Graves, P. M., Gelband, H., & Garner, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008152.pub3 · Cited by 16
Cited by
Cowman, A. F., Healer, J., Marapana, D., & Marsh, K. (2016) · Cell · doi:10.1016/j.cell.2016.07.055 · Cited by 890
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Blasco, B., Leroy, D., & Fidock, D. A. (2017) · Nature Medicine · doi:10.1038/nm.4381 · Cited by 576
Glucose-6-phosphate dehydrogenase deficiency
Luzzatto, L., Ally, M., & Notaro, R. (2020) · Blood · doi:10.1182/blood.2019000944 · Cited by 406
Hemingway, J., Shretta, R., Wells, T. N. C., Bell, D., Djimdé, A. A., Achee, N., & Qi, G. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002380 · Cited by 293
Metadata
- Authors
- Ashley, E. A., Recht, J., & White, N. J.
- Venue
- Malaria Journal
- Published
- 2014-11-03
- Volume
- 13
- Issue
- 1
- Pages
- 418-418
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2144016867
- Cited by
- 252
- References
- 32
- FWCI
- 20.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.